Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Accepts healthy volunteers

The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD

ClinicalTrials.gov ID: NCT02477748

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02477748. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 16, 2026, 11:05 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is a multi-center, randomized, double-blind, placebo-controlled, phase 3 study of MDX (1400 mg daily) for 10 weeks compared with placebo in adults with ADHD. The study will be comprised of Screening, Washout (if required), Treatment (total of 10 weeks) and Follow-up periods. Approximately 750 patients will be enrolled and undergo initial eligibility assessments.

Study identification

NCT ID
NCT02477748
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Alcobra Ltd.
Industry
Enrollment
283 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2015 (Type not available)
Primary completion
Jan 2017 (Actual)
Completion
Jan 2017 (Actual)
Last update posted
Jan 19, 2017

2015 – 2017

United States locations

U.S. sites
36
U.S. states
26
U.S. cities
35
Facility City State ZIP Site status
Harmonex, Inc. Dothan Alabama 36303 —
Pharmacology Research Institute Los Alamitos California 90720 —
Pharmacology Research Institute Newport Beach California 92660 —
Artemis Institute for Clinical Research San Diego California 92103 —
University of California, San Francisco San Francisco California 94143 —
MCB Clinical Research Centers Colorado Springs Colorado 80910 —
Connecticut Clinical Research Cromwell Connecticut 06416 —
Coastal Connecticut Research New London Connecticut 06320 —
Sarkis Clinical Trials Gainesville Florida 32607 —
Clinical Neuroscience Solutions Jacksonville Florida 32256 —
CNS Healthcare Orlando Florida 32801 —
Miami Research Associates South Miami Florida 33143 —
Institute for Advanced Medical Research Alpharetta Georgia 30005 —
Goldpoint Clinical Research Indianapolis Indiana 46260 —
Lake Charles Clinical Trials Lake Charles Louisiana 70629 —
Kennedy Krieger Institute Baltimore Maryland 21205 —
Rochester Center For Behavioral Medicine Rochester Hills Michigan 48307 —
St. Charles Psychiatric Associates - Midwest Research Group Saint Charles Missouri 63304 —
Premier Psychiatric Research Institute Lincoln Nebraska 68526 —
Center for Emotional Fitness Cherry Hill New Jersey 08002 —
Global Medical Institutes, LLC, Princeton Medical Institute Princeton New Jersey 08540 —
The Medical Research Network New York New York 10128 —
Richard H Weisler, MD, PA Raleigh North Carolina 27609 —
Neuro-Behavioral Clinical Research, Inc. Canton Ohio 44718 —
IPS Research Company Oklahoma City Oklahoma 73103 —
Village Clinical Research Inc Oklahoma City Oklahoma 73103 —
Summit Research Network Portland Oregon 97210 —
Suburban Research Associates Media Pennsylvania 19063 —
Carolina Clinical Research, Inc. Charleston South Carolina 29405 —
Clinical Neuroscience Solutions Memphis Tennessee 38119 —
BioBehavioral Research of Austin at Specialty Clinic of Austin Austin Texas 78759 —
Bayou City Research Houston Texas 77007 —
Psychiatric & Behavioral Solutions Salt Lake City Utah 84105 —
NeuroScience, Inc. (NSI) Herndon Virginia 20170 —
Summit Research Network(Seattle)LLC Seattle Washington 98104 —
Dean Foundation - Middleton Middleton Wisconsin 53562 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02477748, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 19, 2017 · Synced Nov 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.